We are live on
!
Find out more
SHI
SV Health Investors Portfolio holdings
AUM
$32.3M
1-Year Est. Return
20.15%
This Fund
S&P 500
This Quarter
Est. Return
+10.75%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$204M
AUM Growth
-$25.2M
(-11%)
Cap. Flow
-$36.5M
Cap. Flow
% of AUM
-17.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Repligen
RGEN
|
+$3.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AdaptHealth
AHCO
|
+$23.5M |
| 2 |
BCYC
Bicycle Therapeutics
BCYC
|
+$16.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
SAM
FCOMV
LUGPSI
VCA
PGM
ACM
KCM
KXA
SV Health Investors's Q3 2021 Portfolio in Review
As of Q3 2021, SV Health Investors held 8 positions worth $204M, down 11% from $230M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
SV Health Investors withdrew a net $36.5M in Q3 2021, reducing 2 holdings. Its largest reduction was AdaptHealth, cutting an estimated $23.5M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
Against the trend, SV Health Investors opened a new position in Repligen worth $4.2M.
- SV Health Investors's largest Q3 2021 buy was Repligen: 14,541 shares worth $4.2M.
- SV Health Investors's biggest Q3 2021 reduction was AdaptHealth, cutting an estimated $23.5M.
- SV Health Investors's ten largest holdings make up 100% of its $204M portfolio in Q3 2021.
- SV Health Investors opened 1 new position and closed 0 in Q3 2021.
- SV Health Investors's portfolio value fell 11% quarter-over-quarter to $204M.
Based on SV Health Investors's 13F filing for Q3 2021, filed 15 Nov 2021.